Allena Pharmaceuticals Inc ALNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 3:05 PM EDT
0.9015quote price arrow down-0.0204 (-2.2074%)
Volume
423,872
52 week range
0.75 - 2.78
Loading...
  • Open0.929
  • Day High0.94
  • Day Low0.90
  • Prev Close0.9219
  • 52 Week High2.78
  • 52 Week High Date01/26/21
  • 52 Week Low0.75
  • 52 Week Low Date07/27/21

Key Stats

  • Market Cap72.25M
  • Shares Out80.14M
  • 10 Day Average Volume0.89M
  • Dividend-
  • Dividend Yield-
  • Beta2.17
  • YTD % Change-29.62

KEY STATS

  • Open0.929
  • Day High0.94
  • Day Low0.90
  • Prev Close0.9219
  • 52 Week High2.78
  • 52 Week High Date01/26/21
  • 52 Week Low0.75
  • 52 Week Low Date07/27/21
  • Market Cap72.25M
  • Shares Out80.14M
  • 10 Day Average Volume0.89M
  • Dividend-
  • Dividend Yield-
  • Beta2.17
  • YTD % Change-29.62

RATIOS/PROFITABILITY

  • EPS (TTM)-0.92
  • P/E (TTM)-0.98
  • Fwd P/E (NTM)-1.23
  • EBITDA (MRQ)-42.772M
  • ROE (MRQ)-286.50%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)80.54%

EVENTS

  • Earnings Date11/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Allena Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Allena Pharmaceuticals, Inc. is a late-stage, clinical biopharmaceutical company. The Company is engaged in developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. The Company is focused on metabolic disorders that result in excess accumulation of certain metabolites that can cause kidney stones, damage the kidney, and potentially lead to chronic kidney disease (CKD) and end-stage renal disease (ESRD). Its...
Alexey Margolin Ph.D.
Chairman
Louis Brenner M.D.
President
Geoffrey Swire
Chief Operating Officer
Richard Katz M.D.
Chief Financial Officer
Address
1 Newton Executive Park Ste 202
Newton, MA
02462-1435
United States

Top Peers

SYMBOLLASTCHG%CHG
DFFN
Diffusion Pharmaceuticals Inc
0.5086-0.0124-2.38%
WINT
Windtree Therapeutics Inc
1.88-0.02-1.05%
IDRA
Idera Pharmaceuticals Inc
1.05-0.02-2.31%
CYCC
Cyclacel Pharmaceuticals Inc
5.90+0.35+6.31%
BBI
Brickell Biotech Inc
0.73-0.0101-1.3647%